Schedule 13G ownership disclosure
CHEMOMAB THERAPEUTICS LTD
Ordinary Shares / American Depositary Shares · CUSIP: 16385C104
Event date: 2025-07-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 13,213,260 · Class: 3.2%
- Morgan Stanley & Co. LLC
Shares: 9,275,360 · Class: 2.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000497
- Form type
- SCHEDULE 13G/A
- Filer
- Chemomab Therapeutics Ltd.
- CIK
- CIK 1534248
- Filed
- Aug 07, 2025
- Reporting period
- Jul 31, 2025
- Description
- Schedule 13G beneficial ownership